|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 14 July 2005
doi: 10.1242/dev.01935
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cellular and Molecular Medicine, Glycobiology Research and
Training Center, University of California San Diego, 9500 Gilman Drive, La
Jolla, CA 92093-0687, USA
2 Department of General Zoology and Genetics, Westfälische
Wilhelms-Universität Münster, Schlossplatz 5, 48149 Münster,
Germany
3 The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037,
USA
* Author for correspondence (e-mail: kgrobe{at}uni-muenster.de)
Accepted 9 June 2005
Mutant mice bearing a targeted disruption of the heparan sulfate (HS) modifying enzyme GlcNAc N-deacetylase/N-sulfotransferase 1 (Ndst1) exhibit severe developmental defects of the forebrain and forebrain-derived structures, including cerebral hypoplasia, lack of olfactory bulbs, eye defects and axon guidance errors. Neural crest-derived facial structures are also severely affected. We show that properly synthesized heparan sulfate is required for the normal development of the brain and face, and that Ndst1 is a modifier of heparan sulfate-dependent growth factor/morphogen signalling in those tissues. Among the multiple heparan sulfate-binding factors potentially affected in Ndst1 mutant embryos, the facial phenotypes are consistent with impaired sonic hedgehog (Shh) and fibroblast growth factor (Fgf) interaction with mutant heparan sulfate. Most importantly, the data suggest the possibility that defects in heparan sulfate synthesis could give rise to or contribute to a number of developmental brain and facial defects in humans.
Key words: Cerebral hypoplasia, Heparan sulfate, Fibroblast growth factor, Sonic hedgehog, Mouse development
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
R. I. Zuberi, X. N. Ge, S. Jiang, N. S. Bahaie, B. N. Kang, R. M. Hosseinkhani, E. M. Frenzel, M. M. Fuster, J. D. Esko, S. P. Rao, et al. Deficiency of Endothelial Heparan Sulfates Attenuates Allergic Airway Inflammation J. Immunol., September 15, 2009; 183(6): 3971 - 3979. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hu, C. Wang, Y. Xiao, N. Sheng, Y. Chen, Y. Xu, L. Zhang, W. Mo, N. Jing, and G. Hu NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development J. Cell Sci., April 15, 2009; 122(8): 1145 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dierker, R. Dreier, A. Petersen, C. Bordych, and K. Grobe Heparan Sulfate-modulated, Metalloprotease-mediated Sonic Hedgehog Release from Producing Cells J. Biol. Chem., March 20, 2009; 284(12): 8013 - 8022. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Frederick, A. T. Tafari, S.-M. Wu, L. C. Megosh, S.-T. Chiou, R. P. Irving, and J. D. York From the Cover: A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation PNAS, August 19, 2008; 105(33): 11605 - 11612. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Pallerla, R. Lawrence, L. Lewejohann, Y. Pan, T. Fischer, U. Schlomann, X. Zhang, J. D. Esko, and K. Grobe Altered Heparan Sulfate Structure in Mice with Deleted NDST3 Gene Function J. Biol. Chem., June 13, 2008; 283(24): 16885 - 16894. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pan, C. Carbe, A. Powers, E. E. Zhang, J. D. Esko, K. Grobe, G.-S. Feng, and X. Zhang Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction Development, January 15, 2008; 135(2): 301 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Habuchi, N. Nagai, N. Sugaya, F. Atsumi, R. L. Stevens, and K. Kimata Mice Deficient in Heparan Sulfate 6-O-Sulfotransferase-1 Exhibit Defective Heparan Sulfate Biosynthesis, Abnormal Placentation, and Late Embryonic Lethality J. Biol. Chem., May 25, 2007; 282(21): 15578 - 15588. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Fuster, L. Wang, J. Castagnola, L. Sikora, K. Reddi, P. H.A. Lee, K. A. Radek, M. Schuksz, J. R. Bishop, R. L. Gallo, et al. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis J. Cell Biol., May 7, 2007; 177(3): 539 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abramsson, S. Kurup, M. Busse, S. Yamada, P. Lindblom, E. Schallmeiner, D. Stenzel, D. Sauvaget, J. Ledin, M. Ringvall, et al. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development Genes & Dev., February 1, 2007; 21(3): 316 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pan, A. Woodbury, J. D. Esko, K. Grobe, and X. Zhang Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development Development, December 15, 2006; 133(24): 4933 - 4944. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ledin, M. Ringvall, M. Thuveson, I. Eriksson, M. Wilen, M. Kusche-Gullberg, E. Forsberg, and L. Kjellen Enzymatically Active N-Deacetylase/N-Sulfotransferase-2 Is Present in Liver but Does Not Contribute to Heparan Sulfate N-Sulfation J. Biol. Chem., November 24, 2006; 281(47): 35727 - 35734. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. McDowell, B. A. Frazier, D. R. Studelska, K. Giljum, J. Chen, J. Liu, K. Yu, D. M. Ornitz, and L. Zhang Inhibition or Activation of Apert Syndrome FGFR2 (S252W) Signaling by Specific Glycosaminoglycans J. Biol. Chem., March 17, 2006; 281(11): 6924 - 6930. [Abstract] [Full Text] [PDF] |
||||